Ginkgo plus Brahmi

Country: Ավստրալիա

language: անգլերեն

source: Department of Health (Therapeutic Goods Administration)

active_ingredient:

Bacopa monnieri, Quantity: 150 mg (Equivalent: Bacopa monnieri, Qty 3 g; Equivalent: bacosides calculated as bacoside A (of Bacopa monnieri), Qty 67.5 mg); Ginkgo biloba, Quantity: 120 mg (Equivalent: Ginkgo biloba, Qty 6 g; Equivalent: Ginkgo flavonglycosides, Qty 32 mg)

MAH:

Australian Natural Health Pharmaceuticals Pty Ltd

INN:

Bacopa monnieri,Ginkgo biloba

pharmaceutical_form:

Capsule, hard

composition:

Excipient Ingredients: magnesium stearate; maltodextrin; calcium hydrogen phosphate dihydrate; colloidal anhydrous silica; microcrystalline cellulose; purified water; Gelatin; glycerol

administration_route:

Oral

class:

Medicine Listed

therapeutic_indication:

Maintain/support general health and wellbeing ; Maintain/support brain health

leaflet_short:

Visual Identification: ;

authorization_status:

Licence status A

authorization_date:

2010-03-05